Skip to content
Toggle main navigation
Immunize Oregon logo
Immunize Oregon logo
  • Welcome
    • Immunize Oregon
  • Vaxx Clinic
  • Events
  • Groups
  • News
  • Opportunities
  • Lobby
    Log in
    Request to join
    Select an available language
    EN

    News

    All
    3-D printing
    Abdul Latif Jameel Poverty Action Lab (J-PAL)
    Abdul Latif Jameel Water and Food Systems Lab (J-WAFS)
    Administration
    Aeronautical and astronautical engineering
    Africa
    Agriculture
    Algorithms
    Alumni/ae
    Alzheimer's
    Anesthesia
    Anthropology
    Antibiotics
    Artificial intelligence
    Asia
    See all

    Results (9)

    A new approach to cancer vaccination yields more powerful T cells

    A new approach to cancer vaccination yields more powerful T cells

    MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines — an advance that could lead to much more powerful cancer vaccines and stronger protection against infectious diseases.Most vaccines generate both antibodies and T cells that can target the vaccine antigen by activating antigen-presenting cells, such as dendritic cells. In this study, the researchers boosted the
    May 13, 2026
    Particles that enhance mRNA delivery could reduce vaccine dosage and costs

    Particles that enhance mRNA delivery could reduce vaccine dosage and costs

    A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine dose.In studies in mice, the researchers showed that an mRNA influenza vaccine delivered with their new lipid nanoparticle could generate the same immune response as mRNA delivered by nanoparticles made with FDA-approved materials, but at around 1/100 the dose.“One of the cha
    November 7, 2025
    A new vaccine approach could help combat future coronavirus pandemics

    A new vaccine approach could help combat future coronavirus pandemics

    A new experimental vaccine developed by researchers at MIT and Caltech could offer protection against emerging variants of SARS-CoV-2, as well as related coronaviruses, known as sarbecoviruses, that could spill over from animals to humans.In addition to SARS-CoV-2, the virus that causes COVID-19, sarbecoviruses — a subgenus of coronaviruses — include the virus that led to the outbreak of the origi
    January 23, 2025
    A two-dose schedule could make HIV vaccines more effective

    A two-dose schedule could make HIV vaccines more effective

    One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, allowing it to evade the antibody response generated by vaccines.Several years ago, MIT researchers showed that administering a series of escalating doses of an HIV vaccine over a two-week period could help overcome a part of that challenge by generating larger quantities of neutr
    September 20, 2024
    A new way to reprogram immune cells and direct them toward anti-tumor immunity

    A new way to reprogram immune cells and direct them toward anti-tumor immunity

    A collaboration between four MIT groups, led by principal investigators Laura L. Kiessling, Jeremiah A. Johnson, Alex K. Shalek, and Darrell J. Irvine, in conjunction with a group at Georgia Tech led by M.G. Finn, has revealed a new strategy for enabling immune system mobilization against cancer cells. The work, which appears today in ACS Nano, produces exactly the type of anti-tumor immunity need
    September 16, 2024
    MIT engineers design more powerful RNA vaccines

    MIT engineers design more powerful RNA vaccines

    RNA vaccines against Covid-19 have proven effective at reducing the severity of disease. However, a team of researchers at MIT is working on making them even better. By tweaking the design of the vaccines, the researchers showed that they could generate Covid-19 RNA vaccines that produce a stronger immune response, at a lower dose, in mice.Adjuvants are molecules commonly used to increase the immu
    September 7, 2023
    Funding to Daniel Anderson’s lab will advance research on new delivery technology for RNA vaccines and therapies

    Funding to Daniel Anderson’s lab will advance research on new delivery technology for RNA vaccines and therapies

    Sanofi will provide $25 million over five years to the lab of MIT Professor Daniel Anderson, to support the lab’s efforts to develop next-generation delivery technology for messenger RNA.Anderson, who is a professor of chemical engineering and a member of the Koch Institute for Integrative Cancer Research and the Institute for Medical Engineering and Science, and others in his lab will use the fun
    April 11, 2023
    Celebrating 20 years of discovery, Picower Institute looks ahead to continuing impact

    Celebrating 20 years of discovery, Picower Institute looks ahead to continuing impact

    If ever there was an event that would seem designed for dwelling on the past, it would be the anniversary celebration of an institute centered on the study of memory, but the first of many insights offered by the 20th Anniversary Exhibition of The Picower Institute for Learning and Memory at MIT Sept. 22 was that memory is all about the future.Ever since University of California at Berkeley psycho
    October 12, 2022
    3 Questions: Daniel Anderson on the progress of mRNA vaccines

    3 Questions: Daniel Anderson on the progress of mRNA vaccines

    Two mRNA vaccines, which received emergency authorization in late 2020, have proven critical in the fight against Covid-19. These vaccines, the first of their kind, were the culmination of decades of research on RNA. Delivered as strands of mRNA that encode a viral protein, the vaccines enter cells and begin producing proteins, allowing the immune system to recognize the virus if encountered later
    May 13, 2022
    Contact
    Immunize Oregon
    PO BOX 4391, Portland, Oregon 97208

    United States

    Coordinator@immunizeor.org
    Links
    • Immunize Oregon Website
    Cookies
    Reselect cookie settings
    Community engagement platform by Hivebrite.